<SEC-DOCUMENT>0001628280-24-010569.txt : 20240312
<SEC-HEADER>0001628280-24-010569.hdr.sgml : 20240312
<ACCEPTANCE-DATETIME>20240312163143
ACCESSION NUMBER:		0001628280-24-010569
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240312
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240312
DATE AS OF CHANGE:		20240312

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHAMPIONS ONCOLOGY, INC.
		CENTRAL INDEX KEY:			0000771856
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				521401755
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11504
		FILM NUMBER:		24742610

	BUSINESS ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205
		BUSINESS PHONE:		410-369-0365

	MAIL ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS BIOTECHNOLOGY, INC.
		DATE OF NAME CHANGE:	20070220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS SPORTS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERNATIONAL GROUP INC
		DATE OF NAME CHANGE:	19860319
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>csbr-20240312.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>csbr-20240312</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-18">0000771856</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-19">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="csbr-20240312.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-12</xbrli:startDate><xbrli:endDate>2024-03-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4ef260702b3d4126a010e79695000e59_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">March 12, 2024</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">CHAMPIONS ONCOLOGY, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:30.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.939%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.674%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-11504</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">52-1401755</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">1 University Plaza, Suite 307</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Hackensack</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">New Jersey</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">07601</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">201</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">808-8400</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former Name or Former Address if Changed Since Last Report)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:13.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:484.75pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:13.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:484.75pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:13.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:484.75pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:13.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:484.75pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-17">o</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION TO BE INCLUDED IN THE REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:46.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:205.75pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 2.02.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations and Financial Condition.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 12, 2024, Champions Oncology, Inc. (the &#8220;Company&#8221;) issued a press release regarding the Company&#8217;s unaudited financial results for its third quarter ended January 31, 2024. A copy of the Company&#8217;s press release is attached hereto as Exhibit 99.1.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained under Item 2.02 in this Current Report shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:213.75pt"><tr><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:46.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:153.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9.01.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements and Exhibits.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="padding-left:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following exhibit is filed herewith:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit No.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:207.00pt"><tr><td style="width:1.0pt"/><td style="width:22.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:181.00pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k1312024ex991xq324.htm">Press Release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k1312024ex991xq324.htm">March</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k1312024ex991xq324.htm"> 12, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k1312024ex991xq324.htm">4</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:47.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.351%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CHAMPIONS ONCOLOGY, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 12, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ronnie Morris</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ronnie Morris</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>csbr8-k1312024ex991xq324.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i135bf95e1b1f4703b905e5a70e78561b_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><img alt="logobranding_headerleftali.jpg" src="logobranding_headerleftali.jpg" style="height:284px;margin-bottom:5pt;vertical-align:text-bottom;width:666px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;        NEWS</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">One University Plaza, Suite 307 Hackensack, NJ 07601 Tel&#58; 551-206-8104</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%;text-decoration:underline">Champions Oncology Reports Quarterly Revenue of $12.0 Million</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Hackensack, NJ &#8211; March 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, 2024</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> &#8211; Champions Oncology, Inc. (Nasdaq&#58; CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today announced its financial results for its third quarter of fiscal 2024, ended January 31, 2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Third Quarter and Recent Highlights&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.3pt">Third quarter revenue of $12.0 million, a decline of 6%</font></div><div style="padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.3pt">Gross margin declined to 35%</font></div><div style="padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.3pt">College of American Pathologists (CAP) has awarded accreditation to US-based laboratory</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Ronnie Morris, CEO of Champions, commented, &#8220;As discussed over the course of the year, we&#8217;re navigating through a challenging economic environment, specifically in the biotech sector, that began approximately one year ago. However, we still remain confident that the tide is turning and we will emerge stronger over the coming quarters.&#8221; Morris added, &#8220;We remain actively engaged with investors in an effort to raise capital for our wholly owned subsidiary, Corellia, AI. Conjunctively, our two lead targets continue to progress with the potential of a licensing deal in the coming quarters.&#8221;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">David Miller, CFO of Champions, added, &#8220;In response to our lower revenue growth, we&#8217;re strategically right-sizing the business to reduce costs and improve short term results as we rebound to previous revenue levels. These reductions will not have a long-term impact on the business and we believe our quarterly results will gradually improve going forward.&#8221;</font></div><div><font><br></font></div><div><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Third Fiscal Quarter Financial Results</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Total revenue for the third quarter of fiscal 2024 was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$12.0 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$12.8 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the same period last year, a decrease of 5.9%. The decline in revenue was primarily from customer </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">cancellations in prior periods which led to lower study revenue in the third quarter.  Total costs and operating expenses for the third quarter of fiscal 2024 were </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$14.6 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$15.2 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the third quarter of fiscal 2023, a decrease of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$635,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or 4.2%.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the third quarter of fiscal 2024, Champions reported a loss from operations of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$2.6 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$379,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in stock-based compensation and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$481,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in depreciation and amortization expenses, compared to a loss from operations of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$2.5 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">inclusive</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$331,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in stock-based compensation and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$575,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in depreciation and amortization expenses, in the third quarter of fiscal 2023. Excluding stock-based compensation, depreciation and amortization expenses, Champions reported an adjusted EBITDA loss of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$1.7 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the third quarter of fiscal 2024 compared to an adjusted EBITDA loss of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$1.6 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in the third quarter of fiscal 2023.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Cost of oncology solutions was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$7.8 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> for the three-months ended January 31, 2024, an increase of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$150,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, or 1.9% compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$7.7 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> for the three-months ended January 31, 2023. The increase in cost of sales was primarily from an increase in compensation expense and mouse costs resulting from some operational inefficiencies. For the three-months ended January 31, 2024, total gross margin was 34.7% compared to 39.7% for the three-months ended January 31, 2023. The lower margin resulted primarily from a combination of a decline in revenue against relatively unchanged fixed costs and higher variable costs due to some operational inefficiencies.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Research and development expense for the three-months ended January 31, 2024 was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$2.2 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, a decrease of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$1.0 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> or 31.7%, compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$3.2 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> for the three-months ended January 31, 2023. The decrease was primarily due to reduced investment in our target discovery program. Sales and marketing expense for the three-months ended January 31, 2024 was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$1.8 million, a slight increase of $36,000, or </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.0%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, compared to $1.8 million </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">for the three-months ended January 31, 2023. General and administrative expense for the three-months ended January 31, 2024 wa</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">s $2.8 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, an increase of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$195,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, or 7.6%, compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$2.6 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> for the three-months ended January 31, 2023. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The increase was primarily from compensation and recruiting expenses and an increase in bad debt reserves.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Net cash used in operating activities was approximately $920,000 for the three-months ended January 31, 2024 and was primarily due to our operational loss, offset by net changes in our working capital accounts and deferred revenue in in the ordinary course of business. Net cash used in investing activities was approximately $125,000 for investment in additional lab and computer equipment.  There were no financing activities for the third quarter of fiscal year 2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Year-To-Date Financial Results </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the first nine months of fiscal 2024, revenue decreased 11.4% to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$36.2 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$40.8 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the first nine months of fiscal 2023. The decline in revenue was primarily from customer cancellations in fiscal year 2023 resulting in lower study revenue during fiscal year 2024. Total costs and operating expenses for the first nine months of fiscal 2024 were </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$43.2 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$43.5 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the first nine months of fiscal 2023, a decrease of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$296,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or 0.7%.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the first nine months of fiscal 2024, Champions reported a loss from operations of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$7.1 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$855,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in stock-based compensation and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$1.4 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in depreciation and amortization expenses, compared to a loss from operations of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$2.7 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, inclusive of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$656,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in stock-based compensation and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$1.7 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in depreciation and amortization expenses, in the first nine months of fiscal 2023. Excluding stock-based compensation, depreciation and amortization expenses, Champions reported an adjusted EBITDA loss of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$4.8 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the first nine months of fiscal 2024 compared to an adjusted EBITDA loss of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$400,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in the first nine months of fiscal 2023.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cost of oncology solutions was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$22.2 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the nine-months ended January 31, 2024, a slight decrease of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$43,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, or 0.2% compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$22.2 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the nine-months ended January 31, 2023. For the nine-months ended January 31, 2024, total gross margin was 38.7% compared to 45.6% for the nine-months ended January 31, 2023. The lower margin resulted from lower revenue against a generally unchanged cost base. The variable cost component of cost of sales did not decline meaningfully despite the lower study volume due to some operational inefficiencies. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Research and development expense for the nine-months ended January 31, 2024 was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$7.5 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a decrease of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$1.2 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or 13.8%, compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$8.7 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the nine-months ended January 31, 2023. The decrease was primarily from reduced investment in our target discovery program. Sales and marketing expense for the nine-months ended January 31, 2024 was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$5.3 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a slight increase of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$135,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, or 2.6%, compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$5.2 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the nine-months ended January 31, 2023. The increase was the result of an increase in compensation expense. General and administrative expense for the nine-months ended January 31, 2024 was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$8.3 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, an increase of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$811,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, or 10.8%, compared to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$7.5 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the nine-months ended January 31, 2023. The increase was primarily due to an increase in compensation and recruiting expenses and allowances for bad debt, offset by a reduction in IT costs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Net cash used in operating activities was </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$4.3 million</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for the nine-months ended January 31, 2024. The cash used in operating activities was primarily due to the net loss from operations excluding non-cash expenses. Net cash used in investing activities was $950,000 and was primarily from investment in additional lab and computer equipment. Net cash used in financing activities was approximately </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$382,000</font><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> resulting from repurchases of common stock and was offset by proceeds received from options exercises.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company ended the quarter with cash and cash equivalents on hand of approximately $4.5 million.  The Company has no debt.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Conference Call Information&#58; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Company will host a conference call today at 4&#58;30 p.m. EDT (1&#58;30 p.m. PDT) to discuss its third quarter financial results. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To participate in the call, please call 877-545-0523 (Domestic) or 973-528-0016 (International) and enter the access code 860900, or provide the verbal reference &#34;Champions Oncology&#34;.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Full details of the Company&#8217;s financial results will be available by or before March 18, 2024 in the Company&#8217;s Form 10-Q at</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#333366;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">www.championsoncology.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">* Non-GAAP Financial Information</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">See the attached Reconciliation of GAAP net loss to Non-GAAP net loss for an explanation of the amounts excluded to arrive at Non-GAAP net loss and related Non-GAAP loss per share amounts for the three months ended January&#160;31, 2024 and 2023. Non-GAAP financial measures provide investors and management with supplemental measures of operating performance and trends that facilitate comparisons between periods before and after certain items that would not otherwise be apparent on a GAAP basis. Certain unusual or non-recurring items that management does not believe affect the Company&#8217;s basic operations do not meet the GAAP definition of unusual or non-recurring items. Non-GAAP net loss and Non-GAAP loss per share are not, and should not, be viewed as a substitute for similar GAAP items. Champions defines Non-GAAP dilutive loss per share amounts as Non-GAAP net </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">loss divided by the weighted average number of diluted shares outstanding. Champions&#8217; definition of Non-GAAP net loss and Non-GAAP diluted loss per share may differ from similarly named measures used by other companies and may not be applicable for the current reporting period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Champions Oncology, Inc.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&#38;D solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">This press release may contain &#34;forward-looking statements&#34; (within the meaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties.  Champions Oncology generally uses words such as &#34;believe,&#34; &#34;may,&#34; &#34;could,&#34; &#34;will,&#34; &#34;intend,&#34; &#34;expect,&#34; &#34;anticipate,&#34; &#34;plan,&#34; and similar expressions to identify forward-looking statements.  One should not place undue reliance on these forward-looking statements.  The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors.  See Champions Oncology's Form 10-K for the fiscal year ended April 30, 2023 for a discussion of such risks, uncertainties and other factors.  Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Oncology's future results, levels of activity, performance or achievements may not meet these expectations.  The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Oncology's expectations, except as required by law.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i135bf95e1b1f4703b905e5a70e78561b_4"></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Champions Oncology, Inc.</font></div><div style="text-align:center"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in thousands)</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of GAAP to Non-GAAP Net Loss (Unaudited)</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>January 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br>January 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss - GAAP</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,530)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,439)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,167)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,774)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss - Non-GAAP</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,151)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,108)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,312)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,118)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of GAAP EPS to Non-GAAP EPS (Unaudited)</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>January 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br>January 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8211; GAAP, basic and diluted</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.19)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.18)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.53)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of stock-based compensation on EPS</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS - Non-GAAP, basic and diluted</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.16)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.16)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Condensed Consolidated Statements of Operations (unaudited)</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>January 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br>January 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncology services revenue</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,019&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,773&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,153&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,799&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of oncology services</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,849&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,699&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,151&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,194&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,202&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,494&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,693&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,797&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,761&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,288&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,153&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,764&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,305&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,494&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss from operations</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,577)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,458)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,085)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,735)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before provision for income taxes</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,519)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,422)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,118)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,726)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,530)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,439)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,167)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,774)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share outstanding</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">basic</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.19)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.18)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.53)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and diluted</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.19)</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.18)</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.53)</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">basic</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,593,758&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,558,642&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,538,480&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,532,990&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and diluted</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,593,758&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,558,642&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,538,480&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,532,990&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.807%"><tr><td style="width:1.0%"></td><td style="width:65.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.965%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 31, 2024</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 30, 2023</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(unaudited)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,468&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,118&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,895&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,011&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,198</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,457</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,536&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,318&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,533&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,186&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long term assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,787</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34,311</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,186&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,604&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities </font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,329&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,776&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,969</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,733</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,437&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,391&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Non-current Liability</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,845</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,675</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity (deficit)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,058)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,636&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity (deficit)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,787</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34,311</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Condensed Consolidated Statements of Cash Flows (unaudited)</font></div><div><font style="color:#00000a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br>January 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,167)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,774)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash provided by (used in) operations&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of use assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of equipment</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(595)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,219&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by (used in) operating activities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,321)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,664</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(947)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,112)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities&#58;</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(947)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,112)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchases of common stock</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(634)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from the exercise of stock options</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by (used in) financing activities&#58;</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(382)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,650)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,638&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash at beginning of period</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,118&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,007&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash at the end of period</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,468</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,645</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>csbr-20240312.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:30dedafa-8a11-4fc0-9b4b-2aad9bd67b6b,g:2ccb57a5-4ea3-47fb-9784-fa9af72402fb-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:csbr="http://championsoncology.com/20240312" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://championsoncology.com/20240312">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="csbr-20240312_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="csbr-20240312_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="csbr-20240312_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://championsoncology.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>csbr-20240312_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:30dedafa-8a11-4fc0-9b4b-2aad9bd67b6b,g:2ccb57a5-4ea3-47fb-9784-fa9af72402fb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://championsoncology.com/role/CoverPage" xlink:type="simple" xlink:href="csbr-20240312.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://championsoncology.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_ce7ec77a-c3bf-48b6-9039-31703e0d48ac" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_5f7acef6-8cc6-45bc-a320-9d2fac12a7d3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_ce7ec77a-c3bf-48b6-9039-31703e0d48ac" xlink:to="loc_dei_DocumentInformationTable_5f7acef6-8cc6-45bc-a320-9d2fac12a7d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b9aa85ff-2c5d-4a29-be37-e751939b2208" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ce7ec77a-c3bf-48b6-9039-31703e0d48ac" xlink:to="loc_dei_DocumentPeriodEndDate_b9aa85ff-2c5d-4a29-be37-e751939b2208" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>csbr-20240312_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:30dedafa-8a11-4fc0-9b4b-2aad9bd67b6b,g:2ccb57a5-4ea3-47fb-9784-fa9af72402fb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_WrittenCommunications_f19be451-8966-4d6b-8241-8f7c560c348a_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_d48f1db3-3f56-4241-a00e-018790cc7342_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e482caa1-9507-476f-b9ef-e3f0840cb1bc_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_183deb4a-4777-4d49-b1cb-b728bdb1a985_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_86489297-896d-46a8-a403-17772ad79344_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_3ca9d3ce-7e86-40c1-bbf3-694eec1182dc_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f2eebd0d-19eb-4810-b5fd-7c1d105a868d_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7c1ddc8a-be0c-4743-bd94-a4b3d69685c9_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_2ad90532-bcc5-4038-b5fa-adae92a5db2c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_1b521d58-3b16-4486-a97a-a46af7568d76_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_aba29139-9144-4194-8f59-4d79bf6491ac_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_e292562c-3573-4178-9afc-0fc57c80a0d8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_71c62c1d-04e7-4600-896d-5a29cc2a556b_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7665ce86-c5bb-4f75-8630-c74ab3e00d06_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_9b55622c-b69a-4169-b4b1-efc443f5c60f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_ecd207f0-96ad-4b28-bd37-0f38903c6368_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_04890218-783f-4e2b-ad3b-a5e0a48cad5c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_bff5fcb8-89d9-484d-8538-4517df064f2e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_15762c6d-2957-4e38-a87d-f875ba4ebee6_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_bb974006-ea00-448d-844b-1cedbedb9868_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_72aa0cc8-df8a-4d51-9f60-2e822ed3f81a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>csbr-20240312_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:30dedafa-8a11-4fc0-9b4b-2aad9bd67b6b,g:2ccb57a5-4ea3-47fb-9784-fa9af72402fb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://championsoncology.com/role/CoverPage" xlink:type="simple" xlink:href="csbr-20240312.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_bbc5623f-10ed-4036-bf8b-2dd2152924d0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_DocumentType_bbc5623f-10ed-4036-bf8b-2dd2152924d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3d9b3692-3cda-43d2-a80e-c72ba79cb27b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_DocumentPeriodEndDate_3d9b3692-3cda-43d2-a80e-c72ba79cb27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_da5375f5-7d1e-48a4-85ab-e47c8adb0a23" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_EntityRegistrantName_da5375f5-7d1e-48a4-85ab-e47c8adb0a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_658cf34d-d06b-40c8-87b1-6c151ef1001d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_658cf34d-d06b-40c8-87b1-6c151ef1001d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_52d24dd7-4dcc-4f68-bfc2-87801ad091cf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_EntityFileNumber_52d24dd7-4dcc-4f68-bfc2-87801ad091cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e4c81c76-dabc-4e64-b410-c920844a2135" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_EntityTaxIdentificationNumber_e4c81c76-dabc-4e64-b410-c920844a2135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9972694d-c1c8-46db-b497-321554bbc4c4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_EntityAddressAddressLine1_9972694d-c1c8-46db-b497-321554bbc4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_49ef3cd8-4b3f-449d-821d-1c2bef376e63" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_EntityAddressCityOrTown_49ef3cd8-4b3f-449d-821d-1c2bef376e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c13cac30-e6a9-406f-9f19-cd8ea5f9efc8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_EntityAddressStateOrProvince_c13cac30-e6a9-406f-9f19-cd8ea5f9efc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b09d105c-b093-4431-9f09-ea24e93aaeb4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_EntityAddressPostalZipCode_b09d105c-b093-4431-9f09-ea24e93aaeb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_5474c299-19c7-4daa-938c-71cc19b370ed" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_CityAreaCode_5474c299-19c7-4daa-938c-71cc19b370ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_0dc7b9ac-e558-4ccf-b077-10a1b9b04e0a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_LocalPhoneNumber_0dc7b9ac-e558-4ccf-b077-10a1b9b04e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_89c303e6-f8da-4b88-b1db-17313cc02ab5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_WrittenCommunications_89c303e6-f8da-4b88-b1db-17313cc02ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_994144d7-ad2c-4030-a9cc-b01370dd960f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_SolicitingMaterial_994144d7-ad2c-4030-a9cc-b01370dd960f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_15880cb0-7540-4b5c-9186-04479d17676d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_PreCommencementTenderOffer_15880cb0-7540-4b5c-9186-04479d17676d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_dcb6058e-4126-466f-8f7d-8d2d19d5b30a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_dcb6058e-4126-466f-8f7d-8d2d19d5b30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_9204507b-97c1-49e9-97db-74a49030ec77" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_EntityEmergingGrowthCompany_9204507b-97c1-49e9-97db-74a49030ec77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0ce3965f-2b33-440b-8bb0-d3e76c55a873" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_EntityCentralIndexKey_0ce3965f-2b33-440b-8bb0-d3e76c55a873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_0b49d48d-e7e3-43a1-8298-c0577f4e754a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_AmendmentFlag_0b49d48d-e7e3-43a1-8298-c0577f4e754a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_5f7acef6-8cc6-45bc-a320-9d2fac12a7d3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d80abb-f55e-444d-9669-b1d7f67e708b" xlink:to="loc_dei_DocumentInformationTable_5f7acef6-8cc6-45bc-a320-9d2fac12a7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_ce7ec77a-c3bf-48b6-9039-31703e0d48ac" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_5f7acef6-8cc6-45bc-a320-9d2fac12a7d3" xlink:to="loc_dei_DocumentInformationLineItems_ce7ec77a-c3bf-48b6-9039-31703e0d48ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b9aa85ff-2c5d-4a29-be37-e751939b2208" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ce7ec77a-c3bf-48b6-9039-31703e0d48ac" xlink:to="loc_dei_DocumentPeriodEndDate_b9aa85ff-2c5d-4a29-be37-e751939b2208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>logobranding_headerleftali.jpg
<TEXT>
begin 644 logobranding_headerleftali.jpg
M_]C_X0E@17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    A    <@$R  (    4
M    DX=I  0    !    J    -0 +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P(#(Q+C$@*$UA8VEN=&]S:"D ,C R,#HP-3HQ-" Q,#HU-SHT,P
M  .@ 0 #     ?__  "@ @ $     0   S2@ P $     0   5X
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   ()@        !(     0   $@
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MJ22GZJ27RJDDI^JDE\JI)*?_V?_M$>Q0:&]T;W-H;W @,RXP #A"24T$)0
M    $                      X0DE-!#H      0L    0     0
M"W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T
M26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT
M97).86UE5$585    !0 0P!A &X ;P!N "  5 !2 #@ -0 P #  ( !S &4
M<@!I &4 <P      #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\
M9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M
M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M
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M9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!RP
M"G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S     %!G4$,
M    3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M        4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN
M9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,
M969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!2
M96-T5&]P;&]N9P      .$))30/M       0 2P    !  $!+     $  3A"
M24T$)@      #@             _@   .$))300-       $    6CA"24T$
M&0      !    !XX0DE- _,       D           $ .$))32<0       *
M  $          3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8
M 0"AF9H !@       0 R     0!:    !@       0 U     0 M    !@
M     3A"24T#^       <   _____________________________P/H
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H   X0DE-!
M      ( "SA"24T$ @      &                                #A"
M24T$,       # $! 0$! 0$! 0$! 3A"24T$+0      !@ !    ##A"24T$
M"       $     $   )    "0      X0DE-!!X       0     .$))300:
M      .+    !@             !7@   S0    K $P ;P!G &\ ( !" '(
M80!N &0 :0!N &< 7P!( &4 80!D &4 <@ @ $P 90!F '0 ( !! &P :0!G
M &X 90!D "  =P!I '0 :  @ $< <@!I &0    !
M      $              S0   %>                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     PX0DE-! P     "$(    !    GP
M $0   '@  !_@   ""8 &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( $0 GP,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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MI>3JS^3_ )Z;PR[+N(=V\DL\=:Q-99<($NBI[@/:VR/4J;94_P!KO\&]^_\
MP:MX][<BH6L:YK73 >TL=II]!\/2((W"@0=BE22202I))))3_]+U5))))2DD
MDDE*3$ B#J"G224I))))2DT"9[ITDE*30)GNG224M ^Y.DDDI22222E))))*
M4DDDDI__T_54E\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27
MRJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?_V3A"24T$(0
M5P    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !0
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M ?_$ 0$  0 " P$! 0             %!P0&" ," 0$!  (# 0
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M$0   .J0
M
M
M
M
M
M
M
M    "/WTU&Q6C=],_3?;J]B3TD
M             &EV:O/G7X]<7*7QG 'UA8E.[T#R>QO56V
M                               !1O4Y7.G8XOGG   'UA?G*Z_0?([(
M                                            %)=/E<U]KB #TQF3
MTWCM]/'. )Z&;L[SGII6.0
M     #59Z_%WI?,>.<"1TWZ*X_:MSG]'*UV\,XJR_P _G'L<7UQGL'SWI-BA
MF                                            '+/=X%2=#G#.TW[
M'\[Z7;*]@ " EA^,MBAF
M    'EG'!WJO)8FVHZ.XW:O/E]8:39JT[T>9LL,]W\SJ^F,@1N^DCIN/C./3
M&?+./7&1B;:Y>NP\<X]L9^,X \F/?&WZ>.<>V,B/WTS==OO&?/./O&1\9QZ8
MSC;:^N,^F,@                           :Q/!Q+Z;RP'<WE_5S<4L/)
M%Q#Z?RV)MJ+^Y/7Z#Y'9^,XY.[WGO3&9/3>[>9U:7Z?+Z(X_:Y6[OG^N?/\
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M_5+%?ZPJ^]0W6M:R]=K6H=#FCM<.SJ5[H#D]C[QD
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M_:J]BQJ=W2[-67CD^F8"6':H+%47^?*1[VG1Z
M      YG[7#I;I\L>^N>N?/^CL&I<  TZS6^&-TK6@  /+.*:Z7,VVO8CM])
M'3?8X9ZEO\ZT:-^L;U&QJ5V/WTWNK;IOH\R<CEEHY-%M5=QK6?S+9X)Y6.0
M                              ""EAXI]+YC!WT'MC-Y\OK6[S^C/0RP
MTL=3W^=0_5Y/MC/7/G_1[O5M  #2[-6#EBTVS5QLXKZW3MWG]&T:-^O;E/<:
MUFK[U#,UVM>AT:QNT(:6+ZQF;CEL&G<H7K<CI_A]X
M             "KKU#E/O>?\\X    S]-^W/,^IEHY  !5-_G[C7L^3&-MKL
MT$]67Z%ETKU;7*-C4[VC6JD]%+#21SD4LAKOH=JI:]#H:U-!M4%@
M                         5A>H<N=S@X&^@  &7KMTOQ>Y;_.Z0
M                                       $-)%1'5Y-37^=#RQ@2D<E
MK4.A?'*ZT_%,                                               !
M"RQ8.VF9KO-Q2_H
M
M                                              ,?.,C&0
M,?.,C&0  //./P]<9 Q\X]\9\,ZY&-@ ,?.,C&0
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MBEV:&8
M
M
M
M
M
M
M
M
M
M
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M%F*WH#0D\9$@I*G*?EYIX@5K)"N@> O ;HCIW)"FG7S<7S"+QIK[ES1/FO\
MDR$55?\  B*JOC1%72HJ+Q453@0J*^%!5?C30=1.R2 D9! ;@IR;8#I", N@
M(*K<<.D(J*<IH 5I$!MULS-(PD;L5$'[9O70V++<%.3; =  A&[)(":AHJ!'
M'I;!I&VXX=*,H)-Q@Y,L@)>@) ^ B3@_@.,VFF 0S 6U?>:$A*$(BP'4<MPU
MT4="=6,"'( #1\&P;C,^H<SF0E#; 0BAI&T1 B!S8CB0QVV^2HBD\^K1"R*C
M]J/6Y&'DXTVBG#$15D!#X<!**NOB:.O=:'+ZA;DH@C*Y&CW(?N4ZHZ+TR4%#
M;D(@I+_&P^K9.2.9'*14-]" Y?4)/<P E%77Q-/O.8*]]-'T],):(GW"]/W2
M=34CI1I59;TLGF?W"]+#OIF,A!+U_P +\I'$8=],FSZ2C\R5QP6G?6^F\^AH
M#Z@#3GJZEIS$9O+7K?3^[^HS($--OH(HO+3DD31N6B#]Q_)9*\S?12?DHXCS
MW6O^U3__V@ ( 0,  04 _P!;LW!'13V4U^9-:&>RN@=$O,,B6#6GL@X>E7GX
M$73,]P-1Y@.>7ID_ITJ\_P"#$R'ER?+Z?"B*NO1/2HJ>!A@G":;Z!\LRG_2!
M555X-MD:L8T1T((*:(473^. M.LDVK#!.$PP+0^6LD]U'P %,HT86A\+[ N"
MPP+0^6E7DADI+PQC').$B6#6BRAZ9RB*J*BIQ5T>**B\$).*&B\>I."JB:1>
M>E5$UU)QZDXJX*:1>?!51.**B\%)$TBHOQJ4O)KBP'2&GG.@#)27AC'UYZ5>
M6I,LG23&NJD,'A<F>UB_G<^7'>]J>]T-LN*!HJ*CGRB2BL=]' F2/5/%^WE?
MZ,PW'!^HP3+G6!>_J9-(B#'.DG-U@H[Z.AEM0)70L[V<5\TY]6P9BN/:",^V
M:?&9OM<4X9!/H\<>GUM3%Y-8P45SA,]IE\FU7(NJF.][4]WK<FL"+>->Z@<^
M6.SZA(9MZ..HM8OV\K_2',;;;FR4=*(VH-%[[Q*@0!0G=9($5O%+K+:*.OI#
M*ZV,5\TUA70%QUE6<HO-%YI\8DCS;XQCZF]&"$+[!-EPQT9033K?6+9DPXF1
M:Y-9)"<F>UBTYFX*=..]Z0[Z8,1S=7\L=U$<5IUSY<=[TB$CAY1/P8OV\K_2
M)!!P&8+8+HO?5.:&),.!DFU2;,]76/84 RVH"(K,N,K18KYI<KTA#(M$DLFU
M.,BHW\85-.!TEPQC_%QH30L6VNF83;:\7XP.Z_*ATQ#!O3K:&,>&+2DG-&(
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MX=LMZ;;+A8:S@;% F]L%%>?J.R=!K$KC=MM:E<FC[5<,K]&VAIM.<L^ C6'
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MHDB7:2VLD+A=Q7\:SG=KIF;ETBR;;SY=G=V:;<H]]HD"WURO[;.0*U@=H,A
MRF%H,_$7?$;++A[-B:8L&[YC%0LOBJCM_9Z](795(]K8I8AN#*H,]=PL[LY-
MGY =N8XV ]I7UJ]EVSD9&?:H>.W-W!   (VU+D>BKMTPN?O=2:MM5R.V^4RV
M&';V.]9J'M+)J64W!IY6^LV+!KE:SN)]AAF:[6<W>=L$I*+?Z)09]3F9W;Z)
MG[=;:XU11V>D%'MF0V+D28Z4?E?1V:_]!NNVF:M4BR[<R\CGGV&I#%:VQL%;
MD9_:"9D,P.V; Y.-M;&+'X&@9>/@J!M5)J.0HE+&JP_]JG__V@ ( 0("!C\
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M3@N/8.;E3'+XN+SQ*QAE87X%I9814GD>,5A/WK,5;(_?_DR86_X)A;[!@F/
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M-RAM/*Z[9(GT]A_%P+,MNQ!8V@M2:O(TH.G=N4-%_P!9PF*EQKU\-=9*^/F
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MTET]B9*=')YMEFL;)9^R6KI++$7C ;Y3M&]U^)*NY=JINW?.9KDM>K5C-?\
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M9:%J[&K2K8Z.)'5U)CBKC9O/,W;FW>7CIRWD>I9LG6Z:YJT:+5HX8Q&\>R(
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M2,F8,B'("_D[AK^*R-Y<Q[.;\,MX/B;Y/)Y>)ZMCJ:2#IJRT;RX84Z\C*T8
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EBUFL,H/>[<9&)K?SUG)WYLA8L<OE>*;3PA=\G8NWVO\ W53_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140656930680320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Mar. 12, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 12,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CHAMPIONS ONCOLOGY, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-1401755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1 University Plaza, Suite 307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hackensack<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">808-8400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000771856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 12,  2024<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;
M 4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " #U@VQ8EXJ[',     3 @
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MY68R#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\@RX/J!5Z0B?
M:ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'!=09#K+&))@G6
M0VY6= 9.MO8(72A]95,. 46=W=3%<]0!;\K!XVBLA H#E&^J%977DHHM)]W1
MZTSO'R:/6D;KW$JY]_!*MAQSCG^T_ %02P,$%     @ ]8-L6"0>FZ*M
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #U@VQ8Q?D^/^X    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #U
M@VQ8F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( /6#;%A(=,%Q$@0   X0   8
M  " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #U
M@VQ8GZ ;\+$"  #B#   #0              @ %5#   >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( /6#;%B7BKL<P    !,"   +              "  3$/
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( /6#;%@9117U-P$  "<"   /
M          "  1H0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #U@VQ8
M)!Z;HJT   #X 0  &@              @ %^$0  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " #U@VQ899!YDAD!  #/ P  $P
M        @ %C$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"
(  "M$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>19</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="csbr-20240312.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="csbr-20240312.htm">csbr-20240312.htm</File>
    <File>csbr-20240312.xsd</File>
    <File>csbr-20240312_def.xml</File>
    <File>csbr-20240312_lab.xml</File>
    <File>csbr-20240312_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="19">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "csbr-20240312.htm": {
   "nsprefix": "csbr",
   "nsuri": "http://championsoncology.com/20240312",
   "dts": {
    "inline": {
     "local": [
      "csbr-20240312.htm"
     ]
    },
    "schema": {
     "local": [
      "csbr-20240312.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "csbr-20240312_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "csbr-20240312_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "csbr-20240312_pre.xml"
     ]
    }
   },
   "keyStandard": 19,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 22,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 19
   },
   "report": {
    "R1": {
     "role": "http://championsoncology.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "csbr-20240312.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "csbr-20240312.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001628280-24-010569-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-010569-xbrl.zip
M4$L#!!0    ( /6#;%CX".M>*PX  &^!   1    8W-B<BTR,#(T,#,Q,BYH
M=&WM'?USVKCR]_X5&F[>-9F)C6V^2<)-CM*6:P,9('/WWB]OA"V"7HU-9;F!
M^^O?KFR3.$ ":=H8CLPTQ4A:[9=6NZNU<O;;;.*2;TP$W/?.WYJZ\98PS_8=
M[MV<O[WH-]OMM[\UWIR-)72#KEY0Y[/SW%C*:3V?O[V]U6=#X>J^N,E;AEG(
M<\_E'OOK]][G7-S=87S17_4-F*W?^-_RT !CK$+2$1OY.M &@@XD]6R6](>)
MOCS2'9N'-%ATYS.IP=2I$0DJ=UCGI:!>,/+%A$K@"!)5THRJ5C 7: 9I)&\+
MR9QF_J_+SWU[S"94>X@LS+X:U\>FM@S-L#33BH&LFM:LU6KY&4IG@=\27U)=
ML55UK;L41)QCGG;=SS7.QHPZC;,)DY3@4(U]#?FW\US3]R3SI#:83X$6.WHZ
MSTDVDWDU:[[QYLV;,\FERQIV,!0:H%TT"J9UEH^^/,M'H(>^,V^<.?P;">3<
M9><YAP=3E\[KGN\Q0(#/ZMB1B>@C=QSFJ8_0W@DG3' [FG\F>VQTGK,U$(E'
M)PB)\7K+@^GF3<!.4+?M.6SVB<USA#OGN9%F5G,- WXJ%;-:*I_E4U"WF.1B
MPCP'_LGW+KW)D4A6YSD0;GW$9\S11M1%C8MGK>4:ZHNE"?-I"@4;,0&KC@4K
M!(,"JP=*JP EH@18ER".\US )U,754Q]-Q8*X_LRT&>! Q)2\]U-$L\9^*%0
M3VKAU6.R%>Y(=O(]4XQ-GKB#SR/.!%$XL97KJ=G^E&;XP\&-Y*LT]"FPQW>2
M)UA!0KZCDC60'LTH:*A5#]L6:#IKNB8MR7,R23Y%=\*D!5?R]Q0R#VH;Z2YR
MAQ?9R"H;%<,:%IRB:96I81JL4BO72D R*]7^B]R[&Q/K^X1[VICQF[&L%RV]
M4IK*TUONR''=-(Q_Y537QEDPI: 30X%"BSY'<):@H2W3 &]!;5D/PLF$BODI
M_+J!6:0_K2-XI$NC+K_QZC8PF@F81=*ARQ(@0U\ ?9KMNRZ=!JR>?#A-UF9D
MG30U*($^]*7T)VH"V#<DMZD;3Z+FBYICTFH5W;(LI$X"&Z633!P3K@/A^17?
M5_6:L;K)T,W50PZ@UH+**]Z+I#'6P<)4YM08$#IJVGD.=N*T7L22AI[$\4/4
MFU\,]7,ZI0YZ"'6#F  F?X#S%!PE@[Q:1RL6\ZJ%NLX2;# L:0?,?5%/<!J!
MH8,-:L+=>?WM@$]@M^FP6]+S)]1[>Q* [P$V1?!1U#'@?S.P3+#(U>-MI#05
M@*,L0JQ$IH6FZ[K3'K3>D?[@8M#JDWZK>=UK#]KP\:+SCK3^:GZ\Z'QHD6;W
M\K+=[[>[G0P15%Q)T)\7_8_MSH=!MW-"WNE-G5A&J5C+/-J__F*6C=,E-#.J
M2UO1D#65?]_M79+-'<=WOAVBWQBYT;%[F&M4M4_+ON'3E/\O#,"-FK\2Z3LB
M(3!"O59G0'JMJVYO0*ZN>_WK"W@>=-%"#< ,$;- NCUBEHZ<8])]GWF*!A];
M]XWKPK!>- > /C%KA6*6M&='UO=J-#%B(/Z("#;UA21'R3.C$#.P0!+V#="+
MFYES7'^&,;A2@4@K"D_2T:0#WV@3 #'&89I#Y]H<IM:8EU@/*]>XI,(>$],Z
M(1CT' S)UFA6-T)SVQQ$C]WP ',YL@,MB;P*8)$^7EQ>@=WIDVZGV?W<_?#O
M$]+N-/7G2.ZP1S^-YE%K!L&QDD^TE!.Y$!J08,IL3$4XA'N$RX#88PHK61QG
MGJPGN)_. ?S\B+^F5TN%;2/^@J&7K-)6 ?&Z[RV]5-UNQ#JDK)I>*]0RAA1P
MJEPI;A+OKPM>D]C4FLXP.EW.$CT4<B3?G[])&,^QOFW/]@5LRBJ'WI>PCS;]
MT)-BWO2=]":+&33,(THV%?XWA'.WNQ;! V NO:5B1?(V7GC2V0\./[ G^T+6
MMHKSGKL,.@_!KL=*4,(<MJF99LE8[UT]BUVQWY4I?AW40*G!@,[:\3&%K6Q(
M6B?*N4;)TLRB859*I4>58D>M\)+/H;AXI"PI\07IRC$3Y(]0\,#A-C)HAU5F
M-;$[OQ+6R+#I3R8\P(-^@L:.1)I]O,NF[)\EP':O3UJ3J>O/F=A?6P.A6LJ)
M^TX%S2"%>ZJ?+T'6P9S\-++2;@[I^/KQLE'9Y,CRD%#^ 5G$"\<1+ CB_SX#
M/#/Q02NYADFN/:ZJ]N2<7+GT;WI"^B$'%ZU@5!ZZI2=;Y*93DS?A8U<,_-M%
M7%S--3Y2^POS OC]8O,HY[(KKB ,YZIF;L,HO99KH'3^ #ZP^4-LGHO,E0^S
MN?_ATRAA$)_5&1 +5LJ&N7.YVJ.8+,R 7@E@+Y]2E[1FS XE:!#ICL "L&"C
MM.>N+/37Q?,N___K+U7+K)P&1#*73<>^QXBG?.X3 H)P0]PL"!6,@G(ZK$X2
MVE[#/AUMOES0+%P UJD%8N8:UO+R.-YB%7[V86.\0BZE0V[3RC6J1E6K KNS
M?,BUT]M3)W^1(1S7F++WL"TP03KJ0$>0^#$Q<'Q$FF/JW3"']'$;(9]I($E/
MG= >S-N+X=D<,_L+D6-&Z!2VY*G@F!D:^C,R9*Y_BV+ 1A0.J6J?R(B[:.8X
M" B+QQT0C_1)P">A*ZG'_#!PYR0 'S08S=7(>( _!&(CU]2/0-X[P L!CB#4
MFR=M(]^%R7$<N@D<DQQ!/?O,S/997LDT]9(13;SZ,&]1))EJJ*CJYC6G6MLV
M%'1CZS'K&HK5XM.HK2Z7-4N/U,MN6#;Z2'SHLM&20+:-#O\$V @_^+ZX</,=
M^T_!)2QIS"N&7AQ'!D^_%E&(]+YZ^K*'*B_!PA<-L&/V !GW^4.FH0A"-&)@
M!GLA+.>B58H-&EJR/GCF,) #'A>V)$=FA33?]XA5,'3HN(\A^L'*':Q<AJU<
MWW>Y#0O2N[D$3P?<'?=I$U?\AYBX.]Z02<R<9?MF%BD$<?=,7&MF*T<];>"*
MAA[U/-BX@XT[V+B?:N.N!$,O#E\/5:\I8)PFNJ,19F&>LG6E?XBM QYI]CTF
M/>G7F45'LXZ&QYM9OJCOP?8=;-_!]KVF[6L'0<C$5A:P?+" :RQ@@6G%(WLS
M"QCWW<0"/OI&X^O8P+;G(!\8&<Z)K5*D8*J^D-LQ4P5S#_*7/"" (C 1K=D-
MN1'^K1PC.Z>8TZ0!<=@(IE O)Z2?HHR!44H2GP_2!?"M62L4R!$J9.5490V2
MSER]Y##%EQPP?1Y)R!IJU@I8*3%%0(L+H"BMNW'WP.K;O7OZ.I)JK>'ZEJ=O
MWV^GGE47D&#_02'?C'!_VD15<@W_R<.S# JK/7IDH> QZLI5QY<.#,:PBIC+
M; FKR/.5A0H#IGH!N^-C";Q_AZL3A^B.$.2JFLN=X^2W'*9&3?& -F@1[!L/
M8!RL3>K9&/I2V\:7#; S7O_C4.$$T8$$PK]O'F&IJ8G,PA$]3M;?_46GIYVJ
MGZN4_M9G@4^\77ZXF.0 :AG4X6*2UX?S>(CYX+ZBJ1_9Q[I@+L7RH:4;C.X0
M41@8=T/H,/#=4"X/>>K2H^CW>*$F4WK#M*%@](M&1V [ZM2]I?, B?EAMRUE
MI4RCW<&+)R[4[06#+OF]A2\0?[Y^UWH''PA>$!!==Y#Y6HYLIPRL<EFW2J^;
M,BB67Q"8992>G3(H9CYE\*(OC+4EFQ!+-RQ]9Z/WU83U6!"Z4A6"=L&_C6-V
M\%+)^X4#V_3!H<8&?>,H/&.68\6[!.HKB!3 WM4+9:7-KX%XUR/I&SM.L%YM
M,E5BZ'J(Q@V$-&W/ULD1A@-8/FH9IW&,IY[,TV/",4'E$ J!!9:]P5;,:*""
M'0@W,/3 L?<&J0K4T*,A2#85K8A8(3#*P1L0()07#OD:JGL02!03_4$]>)Z3
M@AGAK),+6 ?31=W5PWG2.&&:0TH*D9E#QDPP"'PHYA;&?,@EJ=5T<UW&X*!5
M&R(^ "%P;W%KK$H@4)4LBG)N"W.&R2.5K&F&0F#R+JJ,),&8NJZ*B8>,. Q"
M;2?1O!%WF1/KG=(2B&#!GV/*ABPBV.J&Z:,3E#V=1'IU7\'O=TZT_ 0#;+YX
M#0Q&0(2_N,)4I<4@$(]+!=<6S\39L/LS*\ /@^T3PF8VFT87@RA^##$OH)09
MJQ.91/(A^@<DXHM#[#0V00@+F\8(;9D&RXK38Q8B'V%?G!ZS5(B\N(/3LY'3
M4],-<]^<GCO71KUDA*<6D<\3;T)!%AR=9UV/%4M!0Y;7:XD8X@U)P[NM?AS+
M%<0ZER!@>Y/"?>=XRSSF#T7H-,6ZLEY0BSU1B(PX)(-443N+72;8OM6FK+PI
MS$<OU[AGRG]Z#62BA> P.WY_O*[< ^RU$#*^[)K9;=BH1+4"6V[#EO6")09F
MU7P:VG>4&&1KZUA]VHWAR0_<#1];':/1#Z/KL=5Q1A-<4K?+Q\;G]-41)'=_
MXJ"J?3$+)D:D;%:KF;.O!8A-QW*BBA0@ NW%$:BC8H>S/-T/XE0"86^H23(A
M>T-045&2/DK8,;?R<.*3K1.??OM#YV)PW6OU,^%<[7"F[.I>^454'?(UY"(.
M"3=-86&G7KJLQ G=.;%IB*4@*L$6WQD-TPS!;01.0(,?73([9&/JCC"-A("4
M=8D[8)48"ST8I.#14(Y] =0YZQW57;G(^?5OI*T8E6U+/8H5W2R^3"5$22^4
M7NCR5\RUE5\,J<(/ND8V<Z[\2]S@M&M$E3-.U.I\W?H[TA]FZ0Z:N:M$95TS
MU]R^>+?MKRA1/VCCKA*UF]JX@J@]TD/\@RAU\O#OF^R55OX^K^\91?D@#V \
MCS-RZ0O!@SVC;[^7W#_1]"_536.("C21P'>YLU0SO0L4'Q;@'E%W("J31#7'
MG(V6KE 5>T;ENM6V&V7 V3G&R$=_^#X_EA.W\7]02P,$%     @ ]8-L6"4B
M=W&# @  B@@  !$   !C<V)R+3(P,C0P,S$R+GAS9-U56V^;,!1^SZ_P>)ZY
M=RFH2:6UJC0IVZJNU?HV&7, JV SVS3IOY]-PA)Z68NTAVF\8(Z_[UP^GV-.
M3C=-C>Y!*B;XP@E<WT' J<@9+Q?.S?4%/G9.E[/9R3N,;S]>K="YH%T#7*,S
M"41#CM9,5TA7@+X+><?N";JLB2Z$;#!>]K0ST3Y(5E8:A7X8#[!A5Z:1GT-.
M"H*/21#@N* ^3K(XPR$A>9+E'^;9A^Q]F8:49D=S<H1C(!&.YT6&D_EQC N2
MD&(>QGYH+-;I1J6*5M 09$KC*MVHA5-IW::>MUZOW77D"EEZH>\'WNWGU;<>
MZNRP->-W(_0FD_6 CSR[G1$% YRJ3/Z&TXHTK5%1":-?+<H'EXK&LS7[41 Z
MB&@M6=9IN##BG$-!NEHOG([_[$C-"@:Y4;X&J^T(<+"MB2Q!?R$-J)90>&OD
MY0PAJPIK6B$UXD_X![($29)X&UNG@[8JK@0ENF^.%V7I\=@N<1#B*' W*G>\
M-X4=.V)<:<(I3(EMOO# ^QLY[,]X6@X#;WH.O3,%U"W%O9<#LR<7/1]>O02W
M"VP7XYB$<Z%[OK7L;&W+>"&V!F.RB:=#]E=0#&/S9!:>:9'^E1))I:A?Z2>O
ME:(%J1FHPSGJ'502BH5CIPD/7?NCE>":3 ;(DP#C([#;)@(H,SY]O:M]08,+
M_= :%\J<0PU;B?[E^G,HIM9O*(RS_Z+ZFF13JS<4J"<6;HG79A^Q?.&<"?,?
MO"2E2<S:;ZX^O7+#]F'WK,'UX'Q_'$N_?P*$]_]/C'HFLM03[S'AD:M.0?Z5
M+_OUXR[?D7>0/Q IJ6E73^>-V^I9VLXXR+F[;+SQ;;/]/KB1>L/VFEO.?@%0
M2P,$%     @ ]8-L6&H04YKY @  . L  !4   !C<V)R+3(P,C0P,S$R7V1E
M9BYX;6R]5EUOTS 4?=^O".$5-XF3-$U%AV #:=*0IK$)WJIK^Z:UYL25XZW=
MO\=.FVVE0Q,L\!(Y]O&]YW[XV.\_;&H5W*%II6YF83**PP ;KH5L%K/P^NH+
MF80?CH^.WK\AY,>GR_/@5//;&AL;G!@$BR)82[L,[!*#[]K<R#L(+A382IN:
MD.-NVXE>W1NY6-J QC3K8?VJF::Q0 $5D DD"<DJ'I.298Q0 %$R,2[8F+U;
M3"GG+"\@)QE"2K*B8J0L)AFIH(2JH%E,W8PWJF1S,_4?!BT&+KRF[7YGX=+:
MU32*UNOU:,.,&FFSB&@<IU&/#G?PS0%^G7;HI"S+J%M]@+;R.: SFT0_OIY_
MXTNL@<BFM=#P1P?.O; /&Y^RR:/MHH.V<MIV^\\U!]L5Z,40@M\B_!_I8<1/
MD822-!EM6A$>'P7!-G-@N-$*+[$*=L/KR[-#IK*QD9!UM,-$H)1CW%FP]RN<
MA:VL5PK[N:7!ZK?L^Y ]J=S3>>NM1:_FM'1$#+]E2-PL-K[%!^3XG/77<WZP
M1016<*OL@(P/;0_*5]<@ATSP@>D!V':&2(TU0S,DU3V[3WCV)']ER)=0KUQH
MK79BJ_3B?L1U'74<3[23XPM8X,O\>,L,\:H:IPGMB#QN?D+"55LVT@O(N?O=
M6?"^7D$'-Q8;)]R=<O2.E.9[(.5U2S\D6@%#U<W.!<IY?Y6<-?ZZ@!T_/+-8
MMW..!?*B ,)35I%LPL:DC-/2Z541IQB+; +\L%AM7_P6^6BA[R+GQU6,IG[@
M,Y5NR_6"]VWR!HOJ"IC">5X5P+$:DPGG8Y+EC!-(J;OL!*V )Q0*D0X=4>=Y
M/YK'9OAH^KAVQ^./5+XRNOX'M;1ZX%1N:^8"" -M!!KWR'%+W?F=<J5;%+/0
MFEM\G-2-==W]6:'W[0X>+OQ@B)ZX0".U^-R(4_=TFK,28))7%:$\%R0#6A*&
M:4&PR),R+1FE\620AMAS.V W/*NF_[$O_CZ=ATT1[P0S>D8QW:,RVGM5'A_]
M!%!+ P04    " #U@VQ8K(H;B:L)   *4@  %0   &-S8G(M,C R-# S,3)?
M;&%B+GAM;,U<;6_;.!+^WE_!\WU=QI1$26319M'+MH=@LVW0IMC%+0X&WY0(
MM:5 5IKDWQ\EVXD42S9)V<H!0>*7\3SS3/AH.,,H[WY]6,S!3U4LTSQ[/_%.
MT 2H3.0RS:[?3[Y??8)D\NOIFS?O_@'A7__Z>@%^R\7=0F4E."L4*Y4$]VEY
M \H;!?[,BQ_I3P8NYZQ,\F(!X6G]L;/\]K%(KV]*X",?;\PV[Q9O R259 F#
MA'D>Q(E D'+,H<^8I%Q&,8_X+]=O?2%X&+,08L4"B..$0QH3#!-&61+[&/GZ
ME<KI/,U^O*V^<;940-/+EO73]Y.;LKQ].YW>W]^?//!B?I(7UU,?H6"ZL9ZL
MS1^V[.^#VMJCE$[K=Y],EVF7H7;K3?_ZX^*;N%$+!M-L6;),5 #+].VR?O$B
M%ZRLL[XW+M!K43V#&S-8O00]'P;>R<-23D[? +!*1Y'/U5>5@.KG]Z_GO9!T
M6EE,,W5=_6XO59'F\EO)BO*"<377T=?>RL=;]7ZR3!>W<[5Y[:902;?;>5&T
MO%91TBI*+ZJB_&<?V'1 ^ >*M]R.]0#!U70_'RK&73G]?+!PK_050AT_X ;,
MX)!7"^IC)L=:NT]0@T,_?L2'6A9YR>8C+(MGF$;(\^J%"_UH#5,YVG$QK7'6
ME^Y&J.JA5)FN0/75LN4:I/+]1#^:297._BS24AN>Y8O%79:NKMS+6>)1KG#H
M04*C"&(9<4A\K)\FL0@C) ),V*Q\6M0SE<'OWS;X-<@>A(D%M[)'HX5:YG>%
M6%4WC5I5]E4@IVM,T 9]-WV.SR4K\^-SG1^39BY:CN=5H<Z+EU1RL9_*\\I?
M:BXUCZ42)]?YSZG^K.;C!]4#6#VH%WR_Q^G6;^)#L8F3%6)/TM864Y'K7<AM
M"5OY2XI\84BHS U_B:O4:=@)R NI"KVW[*#06DR;K>5Y5FT?:W=:W>J\5(OE
M3&*2>)(',$A"K;1*9 PA!9%'8HJ$B /LFRIM%]"1!?>T?6Y@@[\K=%##_]=<
M>SO3M5^"ATJ"G1+=^5N)TH2<DS9W.AY-HB;TFDHULK<7;-7!S"]O\DQ]OEMP
M5<P4)KY@S(,T1+'NT:($<JH2J(($$8P$][@P%>E+YT<69@T':CRP C17XE8>
M]JMO"#L[Q5D0LY)8'P,G66TY&TU*?32:\NFUL9?,QZQ,R\?S3.3%;5[42M0M
M;ZG.\KNL+![/<JEF'@FDXIAI <5:11)3R#W!(8]]PB7W&"6AJ8H,\(XLK%4$
MH!7"+Z .0F<-K ,!523FBC-)XWX1'C@Y=KH\1%ZL!&O!UDG#)OY'D[4%V:;2
M;3[F*OX/4NIEL:S]?BDNB_QGJNG,2(0)]6E<M9(2XH@1R' USM,7 9_)F 88
MVZF^&V@<N:^Q&PMZ@V\K\IYTF:I[>!*<9.W WT',N\D-4'&/XY'ENYO>MF[W
MV-L+]K)057>KM)=Z^[Q<WJGBJAH7%5^21&_T L&H#(2"L2*Z*T7"@YPG 8PH
M5DIX'O&E\89W']B1A:OAH6C@@U4 8!4!J$,PU^[>S.W7[R'S8:?A0:FPDK$I
M1R<I[W4^FIQ-:38E;?P9]T'3T]C^-WW!F"6^4EPB"3VJ.,3$0Y"'B82Q\*2'
M0D8B(FTG3"V$L49+*U"@44$%:S]1:N?%?)3DS-9QAF1*U&ETU$EFT,RH[7'T
M85$GH:XI4;>AO<S.\I^J^,"79<%$:;",6O;'6SXU#/A[ W2@B6-G\$[+I>UI
MM&722:"Y/+H-7+N@CPM57*?9];^+_+Z\T5?Z6Y8]SJIKK12$0:Z0@#C& >22
M8MT)\4!&-"*AH'9-4"?..#W0!AJLL,$:W+8!ZLZ4:?\SF+]3^V-+W:'WV4EL
M0.O3[7?DSF<GN>W&9[?YX+ZGN6_WF:0H#'S(A0AUQQ.0:I?$()-,49^%DONN
M'<\K]CH':7(&M3>OT]@<O:,Y4B_S_]#%V/4OA^E<ON7S5*2EEOH?>F]6I&P^
M\WCH>S(D,.!>!#$F$60TUH+$$4OB4#<M<60JR&WW1Q;B,R#8()K+KR,9^V4W
MC**=W&S868FLGX23N#K<C2:J?BI-,>VP<NA+JE%AH5A]2L0X\ZD74$@]C"'V
M]&:3)"&%6,:4)Q&F'C.N9TW'1Q;.63UDUEB6!V<M[@8MF2,CRX[,C(Q=/]81
MN5L[UG0T7C?6$7ZK&>MZ?^")U&6^+-G\/^EMO3B43_TP\@4,PCC0PH@)I"P1
M$"4BC 5!#$GB=![5@AGY-&J%#32XTX%S9Z),.[&A])T:,6OF[J=0G<2&GT&U
MW;[."50GM=[SIVYK]S'UE?[H+/:$%J,G(<(JACA":'50'.KR)81NO,*(VTZG
M*\=C#:4K+/M)=$W=? !M2\AQ[KR3B].PN1GXH!ES[6CTT7(S_*Z)<NM]>R%\
MT#YDY>?3G%W/XB@*177<*D+.(=8]#B11@*"(,>.!0D@BXX:GY?G(4GC" A68
MN1;:[/>+P9F3G1H,Z5C)H3-T)SVT/8TFB$X"345T&[ANW,ZTHX+-SS.I'GY7
MCS/*=1GP]9Z-1Y3I/5M$(<?<@RH1& =)*"*4V.W97B",LUU;@X(:%6A8VWW:
MR[R8;M$&L'7:G9D3==B6]9 9L"-[Z7'DS5@/H>U]6)_A06Y)N6)\KKLC(7T4
M)PC2B$F(N4\@ET&LNZ. 4!2(*(B,NZ,^D+&V9JU;,6KD87>AK#)DOFL;PMMQ
M!V=#>>B-)RU.A[KI9.7T-6\X:=':<[-)V]:UVGU*YYL;+!#6*O,] F,2)! K
MGT,F _TM5(AA(I@,C:=V+YV/4^,J/.L;3;;R8%K8W-@YU3038@[5;)O!@$+6
M<#9R#=NFL5V^.FP&3O:J:>&7XBJ_SV8\2<)$< ()E11B@B4D84 @#KU8)BC"
MB:^<QGK/&"//].KI<5Z "MIQH-?(C^4TSXWUL%&>$6'W.=XVI>%#O(;/UYG@
M;9/J'=]UF+K*[XH]G$M="M-D?7OT^K+MA7'DBTA"GX:Q+E]:?XS$$B8D#CG#
MBBME/,+8B32.%#4X:*,[5K:^?)F*\@!9<)*F?0(<Y+F'W "1]GD>6:I["&X+
M=M\'!E;-]8^+-%/>C',:8X0BJ!A"U9]9Z+J),8>>4)+K+TK,&[Y>E)$KY_H!
MJ+#!E\SU.*R5)\OZZ<I^6 4U)NY>1;N(#:^C+:^O4TF[B/76TDYC5UE^5==I
M]=?'6?F9+=0L]AE#0A H$\(@EJ$':1(AZ"OB^TH&"?&,__=.%\ X8GS&!!6H
MK01?Y,14?>Y,G81G2M)!;MU,!BCMA<.11=9-9UM?/79]TFIF7(OQQ^F;S2OI
MZE\'GK[Y'U!+ P04    " #U@VQ8Z']9'K<&  !4,0  %0   &-S8G(M,C R
M-# S,3)?<')E+GAM;-6:VW+;.!*&[_,46NWMMH43"< 5>\KK2;9<ZYFX$D_-
MU-ZH<*+$"D6J0#JVWWZ;M)7$L9UP1=::N=&!!-G=?W\$&B!>_W*S*6:?0JSS
MJCR:TP,RGX7253XO5T?S/R[?@IK_<OSJU>N_ ?SUS_?GLU\K=[4)93,[C<$T
MP<^N\V8]:]9A]F<5/^:?S.RB,$U6Q0W <7?9:;6]C?EJW<P886+7;'<V'G+B
M@S>9 64H!9$Y MH*"\P8KZU/I4WM/U:'S#F;2). "(:#D)D%+96 S&B3228(
MPR/M38N\_'C8?EA3AQF&5];=WZ/YNFFVAXO%]?7UP8V-Q4$55PM&"%_L6L_O
MF]\\:G_-N]94:[WHSGYN6N=/-<3;TL5?OYU_<.NP,9"7=6-*UQJH\\.Z.WA>
M.=-TJO_0K]FS+=I_L&L&[2&@##@]N*G]_/C5;'8G1ZR*\#YDL_;[C_=GGTVZ
MM=ELT8>ZPIP7U>KVP%6;1=MJ<5HA%1=FU?K<W:.YW8:C>9UOML7G8^L8LJ.Y
MJVV$-KF$4]9:_ON7BQ=?G-C&4",Y7=#G>.#^'JVU 0Z%FR:42% 7[<Y44;D'
MC8I6ZRKNKBR,#45W=.E#ONSN?&+K)AK7+(7VBAAK(4N2 $((#SI--5CJ99;*
M((FR#^-O?:_1^2XU=7 'J^K3 F^,*6*\_=&*PSMA'IF[$V@_OW?/XB6V75KK
MDI3Q#"@)'C 5*=A,X6/D/:,)TTQX,LCMKZT]]/KKQ)Y$-ZNB#Q$[DYTY$]V#
M)#_&^+[%8FLBW@C<.B_\[NHL5ILQ<M54(RAWEQ9T=S[#J+,08_#G=UEY-K@N
ML@:[V-"U'"/C%R'FE7]3^E^Q#UYR["=YJO&Y=]Z X)Z!422 D\P:J9UE<ABQ
M3YKMQ0";/@/[:_G",+PIF[RY?1]6>:M$V?QN-F'I3<)EDB4@/44UE!&@$F,A
M".F4\988Q@>Q\)357BCPZ:(P6,E)D'"&0V;<5K$3_@/J'TZKJ[*)MZ>5#\LT
M42[CJ(@GJ<5>SBE0TE)('4UHR"@6+'X$,+[K1"].Q-0Y&4_G26#S-B_"[U<;
M&^(R81X'.R]!>.>P%$\5CH2.80"*4..)IBX;@9$O%GL!D4P=B#T5G$3V+\W-
MF4>M\BR_FX[<!Q*$4]3)%+RQ&$A(!5A!"3C-B!+",,J3$5!XQGPO+M*I<S&&
MMI. Y,1[3$%]_X5SMT"76DN6:A3$4>SB1.HM!J$E<*R9$X$UM7!B!$">,-T+
M#CEU.(9J.B4P3O'GNWA979<H2LBP=$;O+<ZH!&H$BE$/U#&+9V0:TC'JST>&
M>T&A?A(H]M1S2DAT==&[>!&K3WGIPM)1[HSC!$)J-)9%:08ZHQHPM&"2#*-T
M:CPNOK'>"P[]D\ Q1-DI$7)1U8TI_I-ON[+9$NTI21S@#X[2<(I1$ W!,!$T
M-R;8$8>3![;[+6:1GP2/_65]83C:3N\D!M/YG0@I'-,:J'9M,6T,:*X<2.H<
MU99+$H;-5K^VU@^ "2]G[BW="Z>\?0527*RK<C=](MY)JXV#D"0XY#F7(;A2
M B6&6FV)",0,2ONW%ONE?L*KF(,D?.'T_QGSI@GE:;797)7W4Z1ZJ30.9CRD
MD*EV!=8JU8I@@4J.(YTCS-AA,\\GS?8#8<)KF,/%?&$:/E1%[O(F+U>_88$3
M<U/@?$A0%$""\<RU;V8(&.W:P8QB-^:]3LFP]:C'-OMQ,.$URH$ROC $%S&T
M! <L;+OW<^VKW?@N0S^6-%&*.$M )H(@REC4:*I2($)(+')D*M-A)<'SMOM!
M,>%URI%DG18<9W5]%>+7L7AG4Y(H5(:R%$2*4R&529PQ>^:I]HGE \N''WG0
M#Y0)+UR.*O$D9IMO-B&NL#?\5ZRNFS4&MS7E[5(S(A(BVSU$CH+00>,O'!>E
M,$)C!QF<E(-(^8[Q?I!,?@%SN+"3X.,4)8NF.$/$;_X=;I?$!:[3) -F>3MC
M)A:4Q>[1\R!3ER1&R3$6,+\QVX^)R:]?#A'SA6DXP?[.MWW>V\*LEL2B$$)Y
M"#*@X]Q04$PK<"21,A,!!\MA(\D#<_VR/^$%ROW%F\B&JK.RW;+:27YI;!&6
M22:-"UD*RCD<YQ+KP'!&0'N6&4>9D7Y8-_"<Y7[;JB:\&CF*I-/#HGU#=]:$
M3;UTB#6.8@8<MQD(95/ D4T#IQ*GV@3)-VYL-#Y;?[F=E^/D]?N@["?R1&!Y
MN)'0:F-4DN'0YQ(/PC!\<@*7V"<F5'-M&2/#7GCMORGS_X7'GMG\X1[-_T7:
MT=AXO7@D*<;W\?C5_8GVH]V$?_SJOU!+ P04    " #U@VQ8-N;VWP$D  !+
M; ( '    &-S8G(X+6LQ,S$R,#(T97@Y.3%X<3,R-"YH=&WM75N3V[:2?M]?
M@77B9+Q%R;R(NLPXKO(9.SDYFSA>VZGL/IV"2$A"3)$*+QHKOWZ[ 5)WS8@:
M:0A*2%7&,Z)( MU?7]% OQJEX^#UJQ&C_NO_>/6?C09Y&WG9F(4I\6)&4^:3
M+.'AD/SAL^0+:33R;]U&DUG,AZ.4V*;=(G]$\1<^I?)ZRM. O2Z>\^JE_/O5
M2_&25_W(G[U^Y?,IX?X/S[CEN/U!SV56WQJT.J;3[YDN<VG'9)VNV[;Z_[:>
MP:WP=7E/DLX"]L.S,0\;(X;OOV[9S8X[26_NN)^.KBW3?/YLY:LI^YHV:,"'
MX;48,%P=1#"]_+(7!5%\_8TI_KO!*XT!'?-@=OW]9SYF"7G/[LC':$S#[XV$
MADDC83$?R"\F_&\&;X27BS_O\@'!<P(>LF* EHU#>O=UQ/L<J(%?/?80[+4A
M=+8.@?1Z3:L8@"3I!F'7J74C/N"A#YR\=MJ3XY//VHM\WWUCM<V;S9_%=/AX
M2&B0_O LB(91/Z:A#Z#]-R*.Q0$;I#"EYI^3X3.2Q-X>7Y*3RT=@=UN3KS=C
M&@\!=?TH3:/Q-2)NRN*4>S3(Z24H)2_G8&RWVY.OBA'L6#])_M_[=W]\6L74
MLIA*FJ71! D&E$AI/V#%U7X4 ^$;0)& 3A)V7?QRX_-D$M#9-0_%O,1-A] ?
ME$'3E HAC>%_OWAS?KDI+KU,_<UKO6ZS9^Z^;#:M^;67XMGQ&FCR^?H$9I5,
M:/C#,^?9VL3SJ8#PDB0*N$\*5$RHC\B\-HDEGK)XS4M!B_OEU@-19?$]L*,G
MA-UO(2._AQQ8D_!T1CX$]&]JD$\93QEQS [Y)_6^L#"!GP9Y_R]B=MJF13ZS
MX+MOW.X-<5VK89OM1M<R6SM!M335/[,DY8-9/E>P+4BBM=ONNW8(]0X3VM8>
M&EKJ6I]Y44Q3'H7768B*";[U[/7MB(XG\%E"?@MQ-,,9^<@F49PFY'\R&L.0
M _QDRL*,D6A OK7LIDE^Y4$ -Y6>]V'4VONN5;8=#Z+K9G #HI8+$%V#X'??
M=&W+NB&_TM@;$<M^&@N]?6B&\*8>&L$IB3,GQR;@#/)SZ#7)U7N:^/0O*;"W
MG_[Q\85!*!D&49\&9!(S#QZ*6IF >27S/V*6,$%@&->4>S#@21Q-.>";I".:
M F0'H#(("WVP%@WXAT0%SD$W9B@.B4'2R*<S>' 89:$'KBD'^ ]X2$./RW=D
M 7X2Q>)*.N*Q3_Z2XH%",> )C@5I;."KX G_HB%<GQ''DK1O'DOM' 3[4WI_
MGP4U<F4AF/.1H?B2?\*7 OQB(GAZ; +DQJR!#I;P(%=<RH;E--T3>)4/HCUW
MDKJVW;ZI2.11Y:]0I]=TD!2?5W ;KROUL53J*'6^D#9QK?U<<^!H'/@ICI*$
M2(^S(+(/VH<XKB;S\<A\"PX_&PKXOAG#4ST:D@\T':'>YPEH\*O;-Q]>D!%-
M"+VC,>IKZGDQ\WDJ'"3DR.^?&GV:P)6 ]M%OBN+98UW ZMP3&UCU,0I#SLBO
M41QS,'FW[WY#^LS-L0$!Q1CS*LPWA+&VS9LW"8&0R<L2I$,T%3:5P?>R.!'$
MQ;]F8'X-<L>$?>_<Q(R$=,J'0,=P"%^(HVPX HWBC2CP)!SBI^"(AM&8>V J
MISR.0GRK09()\_@ C3IXG" >^/ ^CU(FC+L'##"D2>^S(?"33L#0?^5CFC+X
M?A3*D1 ZC)KDG]$=*#<Q+* RJ#50=F,*SX07#SB*C7P2OB*%OPD'HY[%(0X.
M#1C<=H=W,0#/$!\!@QRBJ5^08(S?S55ITA3T0E]/$)< ))>H^ <K7D^]%"(8
M&"X0@@Z!IG<\'<%<IRR!Z24X:Y@9&X"CD2(&8\J!T!Z= "X#X7X Z<D=X!BG
M?(>Z(\GZ"?<YN!K TBAFH,(A+GKS<Q/^"O\$;T:^T1!WIG<1"1@%C0,:B($<
M #V 3V $X&5 SB%X.HD<%,YR L2'Z_!JX#4E ;A7H<C9^0P^RUFT@Q3UEI6W
M &%?1#F(HML?UT5EE<$_A^@B3N"*("12.@ $+DSL,([NTM&JE "H +K#'.\B
M)X9#E%(#R,?L*'(#8<#\S$-*H^I"?/(Q.KGPC)$ "HO'<Q\55-H=XJT/GJPO
MV<JF/,J2^6 "^#=(FN3S"%QG^6SA!4O(AU$*>A&>#?P&T#?$P^%] %T2A:M#
MRT6ESP(.SQ3S_FL>,Q8#$D\=QM3/I&#G0Q]&.%. -.K?@T!S:F3<Y^W^*!W^
MPNG]<1XJ?)2SKBWZY1RC5$0]$B^H=H2BO"?J(7> N^J<@&>O5SS8BN)<F0L'
M?3BAL?3JJJ9(5PF*% !*Z!AL"CPD0J<J27/7040;,:/2I7";O>="-\UC$![.
MH8@HF\1@\V,8)AG$T9B <Y)&8*;)3K%:6\Z91 D723"PE12-X\X%GCR-:BYN
MH7V1,]B\9:=X+_\<Q0N/?L@:?9CSEP8=@#1=T^".SI)G>BGJB9>BJM6S$)9X
MX+!1:7X!YX!MD!4I(F Y1QQ<WT"J$NE0)&GFS^;BD'M@*XJY28A4WPMO(8('
M2G><?9V !\>2/74Z S>E6A76:K:54&'J*'6W:2M!D3T0Y*SK]DHIUW9< UY1
M*=& 9JVF_7PS%UPK]_#'/92'L93GC\5Z$N980(M!V"#L=JZ4\'K5R+#54#(&
MZ',OR#"952T]G$ZO<DD!TP9^G?<ES\&A_L6E-9&<0YM6*8%:74L% OD,5\7X
M@BAT#'+&_Y8?%+;>6#%>RHJ@JX8(5DD%(?X)1"35VJB*H> X2@B7NMK'[53O
MR)30/MN"E#4_L4G>?2TLWRZZ&WN_<)OC 3?XZ#3![^_^\?/GMV^D&JP:ZU:S
MHX+:VR\<7#$CRA)4"5=N+]#7-@@0*R2W48+%-5NJ::K,!8NA?=NI//$IQK$D
M5C%CC3'<,$IVE <9*%+@ %0=*TL"6JY9H8D18S P6+::O><JY%X*6%6MK<O"
MRI&9]#FNQ JXE-N$!BS9EE!?QJ'X_I+ODQM987W'4984:Y)RK4\LZ.$CDFC,
M%M&%6"IF@P'W. OA_Z1)?BPC&*E(9PZ7*V=PV$ZKV5D%A]/#3TI31V96\R?+
MF<!WUZF";^KS4-)!+(=O69^@0\I#H&^QM !W9Z$WHB&N]0_X5^'3%&G9$? 4
M7CR%MXCB=7G%EXOQ#Y)P<[VC5N;C8U&VB93P<44ZFHC-007$2NC.Z@V.77E2
M-M>92N1;<QM2^7JLU): (P?\[.>&.H;$40,NY57E'%RK=B/76;),Q<_KF80T
M@VX4=4>BW$C4DF$)U4S6&M%QDWP29DC8$QI_8<NK5/52 =;"YT0Q3$3A\XI'
M]ZW31J=*.#95LMUNFL^K)-6J("X3KE*RE!*&GU@(IEEN1:#^F(=<E'.!R3\0
MO54R)"'?5E\J4A@PE:*@7I6)MD44U&FV5;)>U2^7'6"]3D.Q!\MBY$BK)--*
M_+>M?FH]MQV#C<_X:KF(4'.K<6&?HM_>3\4&K!@,?LWS6>_!/_%H,B)9(ER8
MI:H94;4-%,GCY=7"\V][MLB5E-+WHG!VFPN%SM)RU(=)50/WL"4PO/Z,A#A*
M$4\FA6]UAR<DP"B+*G'J>5$6YC&FSP8L1J6Q5#*4YR:CV(=P%D:U*.<O"GN;
M9(,:TJ=[F!J6[<ZIL>H'XC:-8E:T+S?Q ?8RS(RROS(NPC^L7AIAV9&H/0JC
M8A/>ZGL?2E>+C0#5;[H[91GR_\$4&Y^CQEN@^V;Y\>YBR/K,^_[:DP&/DY2$
MF'_)16V]_J1 ?!&S^,2RFJWGE5=P.>W*HS_%:MI:9N7>Y^HRV /@<@ZJ3]XH
M]EQ35LY2%A6N;JOW]+-8Y%C7M5R9BL^'!$>!JL]6]?D1U23$4:,^9F\)4203
MF1<7]=J5%TP W<QF9TOEY^49YOH4AG::E@I2ITQA:-=5HO)(W=(L<#!5 ,S9
M%8=6O>Z^+(98H%DY2=IN]29-<4E4 C,'%$H^''Q<:+%DJUY18CT*)N%C%13)
M7L#7.WSU#M]'[O"M23"E9G%M[HU57^RTJH=18SQ87%L49"B3E&@Y5>M=0R8E
M;"4J;.N*+6=1S+H/#G?5LG;7:UE;;K/]O-0P=I>RBGAN]4"BHE"5DJ&L9%FI
M5!4UPNA5RJ>N5*B*448A+NJ!"*U6$_O<%^<'%9GQ,:-XI-8@P\?[+)G@8;WI
M?)PRN3T%U39F>]>]GFT";>^*V(=Q5KV1Z*B1KU8J#6TIHMMP7X73[*I14I0G
M%A6)ULOJVQWUL$+AGJH:M@[B[S8=%?BYHQ"W6BU0_3$DPO&S52DJ+!"CAG(L
MJP%62NOP1NEUB1U"#V^D*E5(7 ?![RHC^$K4$>=$L2H_T4#NIC35LOJ*.(F/
MD_F-$L[[Q/[>^MH HB*L$9*U.D5][7+U)UV<UHJ/_OFS+/DYWZ*"_8MR*UZ9
M4$+KE; 4$LC[D78#X>(5P)FMB\5LOC@51F%#O*& >9FRXF][<@OZEE)I\<:#
M:HLW7K^UNGBSJKG:>M&N7;7U6-_?';-)%GLCBJI+)('& #:Y&#GGUT)K 24]
MQGQ<8?08.#9^@9D","SV>+)M \&YJ#&4M5NTNN$LET<4H:)N71RW+F I<"LD
M!C [A5@0R_B!LB-1TSE8K[5O+>RGK)N?OP0;&X21L!_UW9;Q4..J*!RPF('!
M)+=@.\G/(:B_L?B:;"%TG,F=<C7M2$,\]?:A E7B)/=1)-+&WH+Z>(!]T4 I
M)2U!?,<DD^:X2=Z]_4RNK)6//KS]_ *M2-Y88DM#I8W&2Z?:OK4G"2("_G+*
M/3[!S19%VP.8M4$F@?#S! FZG4[#;;D-T[4=<O4V&J-E\UZ@Y]WK. W7[C9,
MTVJ3JY^QM5F8)[A?"*D7W<[$<ZGGX='Z7N0STFV;O7S#<-[42GQERN*^($[!
M@>^^<5HWFWVUQ,<':%4M!IO5K1DPV&<IY4%2-#[)Q2+OZ+"M7Y@0F#[P= KW
MB144,(?HVS-05:QH#-?-@_<<6.N/_1&T&H1NC?\!Z:K2$;E/!AWXK]T^X<OO
M[NZ:7@'P8E6\"8Y'E131HG6,>H[_(N\A4/CIS9L/2_O8EHQYG8F\V5IVM7'M
M305-_+;/X1.3MH6F*?5&3/3P SGC 9^?>"18-(_[P(+/^;8(!J-8-##Z.@GH
MXJ@D\=RQW)0JP\.\)BZ.,<\)3L/FDV2F)!!]PN=7Q94)KAR/:+QXYLK.6[(M
M[I6=A5>VW\ITSOS1"^4]!HN>@0:?F]Q%>R:Y,!/2(1.!IW#<DVP"3@#^O7PO
MUN[,XVGX1: 9334^(@6K[2>R ]6 (HU3="QD7HXG:,+[++UC+)RW L@MAL@3
M83D9\5B<8D<IGK)Q_JB[* OD^GL$U(COL'44&I\)9OM"T;V'2B;V:<+!J;K-
MGY&%69)ADZ=8Q.P0IF6QV&BV]/"E:?L12\1KBKX_=#!@7KK5>.&;O.7T@!^)
M6\>,R1O$>'P&Y.<%7.X?3G,'6':"1.PC3@WQI614T,A TDPYN\."UP37B;(^
MR%^:I3+AGG 0,AK+\>4O7GA88L H?,5+?8[U65.V"Z(T61VV+F74I8S[E3+6
MQX0(Z,/(.2I><'11O.4-*&,0M ".2)B-^W*OOA 9;&"'@@(:,TN3%&04!'U)
MTG)%LJ8A'M  Q9/79'$, :K/L1UP?DJA%/%@1D(ZAJ_/E;?(#J*GCFI4JN60
MS]?E9[GN0\4:<$^X]84%0DV%*E+6TN>Z'Q3X^3;_?=,'QNWLZ7P&T]YQ^NUF
MUW1L^WC*;M4?(9SOWKQ=*@4&%ZK/HPF >TS!6@X!I7)_!]BJ/XH>C@$6FV#*
M1AS9*7X!_ J_JD_#+R)_FX].-.T+V)0"/2?P($!R T8F4K9?68@U*H.47'UX
M^[\R:2%3\C,R8N"IXR#%%,>"/^#LS.!]/@M6-IG W_ XT>DRC*9RG5N<@YFD
MC;_ Z/,49)2F=-XX%,@#KX' .Q8]0:=\&LF$R5?Y.SB:*3I7HI^AO 432F+6
M!(5P$ 4\$K/,4I3(!O.'HJ\H.#3!+!5#GC_$P-+,+/2%M1.-+G$LQ>7\&!QY
M6Y)[%%B9F&+;4G1M&;8X]=CRC%F(&D+6!E!_BD[@."^>W(F2.<_].!LNU0FM
M5P;F=4,)G@$3^&!OF:Q&':.OR!<AU#Q/->7@&Q ,IN<#_&TIF'Z"7/$CA5(\
M\1K/N>'>7HEWCA*&"35$-I( %3AV/47'5R3(\A:4C2"*OL@]52 <2-Y$7"97
MZ.;GN9F\H+4(:CZ ;*#G_@E=5+EX] O\,Y21SQM/<-GJ]=P74KIYB&?;A*GH
M;SN- @ _^/MRS03[S@MW/)7'NV[1,$NENKCR DR'R"#)L&0TD7/)/7)#CES\
MA/DN_^FA [S\ >:HEO^& 8#:6?X$E^^\=/D34!!Y-G3Y4XSY\K^%9.0>--R.
M#"@TENB^"Q@AN^D.L_\M9$O..DH@Q$X@F!D6V$!,BJ&4[$8J"V1V/VDI@?U]
M@LM\V5*"3E"C< IP627F@K["/TA'D3CJN)BK/]^HM/-]PA$88ZX\0^F#P4$,
M!R$>1H\P%@RR-_GZ_2+']]]+F\L69WS(4/8-Z,& .*:L1)"A=I%$S_TB@05$
M%"BG%3S)0T&$.[,8S9L 9H@*<REP*V(ZJ:\DY_/(+6:# /[:BPSH;F$%1"24
M'[9M9K,\G >V 8$!"%B)+B.C7)I\>35O>R<:1JX^<4Q])K7N5B(.LC2+BP(L
MH(#L<RO6S>3B+C@ERZ$X$M ;X6SE*PK7KHA-DU4"K"VQS:-@*3 XHVPBIH!7
M\RG=1Z)!D?&7\\8;-I05/!076A =<D!+#\ $RBJ:$3K1\O%@6\FT/"=#&*U)
MBER(<=$QEIYO0.]JL-L.'\W]'YYQRW'[@Y[+K+XU:'5,I]\S7>;2CLDZ7;=M
M]?_=>O;XL-;N->UM8>T#0]UN*#VQX%/6YUVYZWAYVO5X>;NG_Q@?_]0#+^D6
M7+V- C!-B=1D409/]Y,75:;*#YV)3&PJ,?)[P;,CF[R<1,;BG%\P8K_Z/:29
MS\'2J,&2>R?V  -6<S4PQE3D"^8*,8;XJN$A&B<)NRY^N0&S#B[/[)J'XHWB
MIIO-3! $!2* R2DAB"(O+[14TY2:*@45D_K%F_/+37'I9>IO7FMUFRVKM_.R
MV;1V7KOOL9;9='O=@QY[_[6V>=B=#PRV=R -*A@L7.S4:;!=>Z_'OA3(E>@%
M 4G ^_KAF?-L8<9]S!E>VY.OQ-J:#ET7$RDA3Y]U-K?HBWSR\WGU]IF7M*85
M36M##9HRT,:EMU_ETML[C%?0IUFJ.MTYXTU.FCC?9V=$G/>X%W9?VAP.]X -
M-DR"REA?3"JW@V@E84Z8X>0^*<97+U[C^O*Q9KQ3$,Z5<LXQM,2Y$D?#ZCBP
M>D#!]JGW12X"-/(A>AYC@\%]TU;1T7A?+(TV1*BU#IZ'9KLW DQ2!U/T[>GF
M?[->SZ#4Q*]LPW7,%R>;/EXM28;[],Y#PK>NNS2,+P;&+:>G8:QA7&\8=PRK
MW=$PUC"N-XQMH]-IJ0?C\TH5_L*21.R<.VY4?$E?O9!8[]..8Z!W L<N1X*M
MZE@]M>1T>MM3CB797:4)/7<6.99FD=HLZKJN9I':+&J[[>I8=%Y.UKSJI#&O
M1-E%5.F]YN47S@0WPF58S%$,\E*BF^/106TI@RC'<JV=4<[1R'!<7?E0;*Y1
M?'DH-KL:Q1K%M49QVW L6Z-8H[C6* 9=;"FLBX5K_U)4&ZM?<UWSTO=W'SZM
ME+_CW[KR79'*]XYSDLIW74Q^JC+]EE.G/06VKGP_F^)N7?FN*]]UY;LN4=:5
M[QI6RE'N(BO?,9(2YX99-R+4,O)3",7I.?)H,%T-?ZKY*YZ  ?=:5Q%K%-<?
MQ;NSB!K%&L4U0;'K:!1K%-<=Q;:"V^O.*W6H*^%U)?R>L9\\BA[/0MQ1$X\G
M#$*$>&&E\6;3='15K_(\LC6/E.=1A:77FD=[\JC"'0SGY7EA+G51&5\BDWHA
MX<WY1#%6^X&Z-#6+)S7"-,(TPC3"!,):NX_6T C3"#N&#G,K0UCN6!;O*T:6
M%]<>L6)D2^7Y:1)5^IT[W_E %%%428<1=D*_[]U/]<W:#;@NW]2$U82MUS<U
M835AZ_7-6NU[>Z@O4]&GJ(ZM@X_:8ZE:9LVW\I';*/19F,C?1%P@FLE]6K3R
MB@;DMT6+[*OLX5V %>^NZ_6:7;E%[H#-=;WN[LN/V:_6.\U^M?WV:I7= G:B
M_6HG&6S+;==GL&U[OP&=USJ-WEQW>*!>5^+HS75Z<YW>!:4WUVE8J0"K$Q18
M*J=YYYW(X?XI]Q@V#9ZR,&./*;2I^=K67E-4>UW+L@W3JO_1R1IT-0-=IU/_
MFF0-NCJ!SFD;EJM!IT'WE'-KF4:G5Z%Y+>V9#L1_6]_=:79<Q:%T&R5B U"T
M[JP>M.5G"RUJ4@;?,;JMLJB[A_.G4G5KKSQHKT*=F=0NK1HTDYZ82;8X"%YS
M27TN]5K5<>E(":"ZF-F/+&$T]D9R,Q";LB":X&KVA6VL!=!U]8Y Q9GD&+;>
M6JLZDSI&J[3ZUDQZ8B9UP5^M,']R8:'L)QK P]# CFG\A:4PA0L+8BVCT^MH
MSUMY)K5U>*0XDUS#[G8UDU1G4OGE"1W"'DKMGUC(8AH( TO],0]YDL:B5/[B
M@MA.6[O>RC/);=>_2./,F=0UG"H/']),JD&FX4A!K"*F=7MYI&BI/(BC,8GF
M&YL>$[H^[J2,*B&XG3Y7H,T[NT\K>309:N2FGR%K6VZ)X]DU:^O#VHYA=G>?
M *-96V/60@SD*,C:"PO)?TM'+"8\]*(Q(U<!>!$;+#ESY]0MFZ33X<.3%Q%K
M#JG-H2NG?&,1S9VGXD[]2Z$5,:'WA-Y]-HAB1B9Q-.4)=CV /PNSFM*OCRN&
MKJ_OMT-=0#!>IBV<=NOKQ-J6;6O6GB-K.X95I@V>9FU]6 O!N+W[M' =C#\-
M&SX<UWNHK\=JE:UNTC'%4W.H;)&@YM 3<ZCT7D3-H:?F4(69QTL(S-^SE&!&
M^V1NC6I;_;>38?^M_J7GKXI\[5[S=TKTBJU9P*)A?#$P;CGGFRW3,+X0&'<,
MJWV^%5@:QA<"8SQ&K:4>C'=TJVK=TZWJ\'ALCV<<K>^3'N7YCO*\HM#M47X1
MA9()BV&2XW$4DF1$8T:B+$U2&OKW[3)^'#'4RWGL?Y;XP>LWFF2G))F2S[BP
M=2+1%%P? 7W_%-46:FQM6B*F5R\WK^%6-[B5*-W0<--P>R3<W%I7!&NXU0QN
M=HEU'O664>OB>(JC)SDVJO0?D0"[)SMPCO)4G@#*2]OCBK<?F'Y]$OD:R+4'
M\J/JF36056+G10.YC+NM@:R!K"R0RSCR3P9DO;BJ1UF[45["XNH?X@_F$PJC
MHD.VLL":Z!76RI?I-,DTR33)=I%,KUN?_28?RS'<GF-T]#%#=>"4VS7:+=VY
MI@:<<KI&JVMJ3M6 4[;1ZU7(*;U&]X@C+N14ML6<C\RZJ8G5@RSU\2E6OZ-0
M+@PG!_D)&B<7AY.#O!2-D\O#R2$^DCHX$2[6RY3"<^%?GT]?OX(?Q<B7GO5G
MEJ1\,+N'TO0T>_?L+1F8]7'FW[5[31N=O$F4<.RC<!VS0#0INKGC?CK*N;9\
M8TYZ<W$+[2<1NF ;M\B)OW[51X(MCV/YYVB^TC2A0];HQXQ^:=!!RN)K&MS1
M6;+Z^C$/&VMC+_E:%9EU&X4^"Q/F$_A-[)>DF.C_!PUHZ#'R:<18FNSDI3+3
M> !S8QH/@7THFVN!A<="8#BN+Z)8+: F9!E&']!)PJZ+7VY\GDP".KOFH1B#
MN.DF?WJ.3WS!FAB+]\G+.68ZO6;7["!L\I I?W&.J*9 U)IJDM?:;K/3[NR\
M;#:MG=?N>ZS5:O;:K8,>>_^UKGG84Q\<K+O78Q^;^SW&BN06^RAAI]26ZW_1
M,*/QC#B606S3;AVTZG"QU'LSB7E '%/0SGG<\L,1EV[*;(A7G,)764@SGX-U
MVMT[026J7O+6R5N:C$3_20]_87]E?$H#@-3^AX3I'2 *QE MH]6N_P*;QER=
M,&>9>!ZV7M=X(G*_\3R83)J0F'D,M#;$-P8)6?J818X:9HLZ1K=7MN'I/8RO
M04:PADSJ&F;I(ZR/R*0+\^ED#S,OBV-PY A-$K;ISIWY.GO7T4V0%6>193AV
M_;V%F\W$JE*Q^.<HI<$Q=$'9-(5R*-Q.'\LQK%ZWH$@5<O"H12[ECP&]:&SU
MC);;T=A2?ON8TL]XP% 5ZUQA%++[7_M4W[RP./RW"8MI"@,G :,)(P+_C6C0
MR. /:7 O,2YO&V[I/K4Z+G_RY(E3.F.GX_)'M#,#79'.Q'H++K5,QN"4'ZX<
MZAO[H7)P=("N-I,ZAM6ML-/XI;D1(FD71.!'I"P>'R%4KR'DK*Y.Y:O.H@HY
M=&'^PD]1Y-_Q(+@PY\#1N7O-(IVYEYG[[6[ :3.INKF2*A.WVT:GJS/()_/5
MM!Q=AAPY+<.Q+"U'RJ_$Z,/GSB.;,2].G-"9V*Z%*4_J>7'&?!)PVN<!3SDK
M[=BHK'./='BIDFKU>!E"]1(V&G/UPES;;"F;@CJ#U?AZY\QN\TJW213CQG,2
M#4BTMD!_C_DY\[2-93BFSJTISR3;K']=;%WTQ6JM_))J()>V]-;JU=Z3.WL6
MZ;6WIZ+U6S9@H!-\$K,I"S-V:9Z"8SAV686@786GYI)M=#KU+]&IQTK<%A]!
M;Z196JJRC%Z[IU/L*O@V9XBMCN-H;"F_?*/T,RXLLGT?A8W"9AT[!5;?&*IM
MM)R.#G359E+'<'KJ'A>A<_Q*Y.R6]=LON3Z;75B8WG)TC*XXBURWK";3 ?IA
M ;H.S+<'3UVCVW)U\*2"+W9VV.H9[8[&UMZ!N:L#<QV8?THC[\LH"@"!R7??
M=&VK<R-V@Z<S<N6S ?=XNOO<Y/,,^*YLPW2[I1N=U]0*U)!!+:-=Y6D>1PIP
M%5$+>SJQHF8Z.4!9[%F^OE>#G,O:]G)\ JDBUF>RO^SH#*HX^:%%58OJF6YA
M4T94MS=C4[+[U45W7*N&([\7O6K(C@9KGU+X!P_J2G S@>B7\F,0W25D6YL;
MI=&UVEL-$Q%/VDD-L- T)1Y*MU)K-\W6:5JIV?MU)RMWK6T>=N>#@]V/!@^$
M2P_&L+V-KV[Q'11L//4>/B&_PM=&"7D'PNRCMEGJEE:FV9>:H6,9R[S-/SV?
M)F/[-KXKW0#L$BCWR+9W-<RN"+L]$'9[$$?CI8HHZH%G)1(NWWWC=O>2HCW.
M!2@%$O7R??MKE"<Z9^'\Z'F"M7GE#--[EI(@2O0Q#[7><G_5,:QVI\ZK,QIO
MM<(;;FMJ58*W\W*%=IS-XV,-E\QHI!&V#XQ"CP<,SR$7VAH_Q=]%2]A)'$TY
MA%*D/R-7&69'>/BB<)^B\/%.4]WM>(55%'4EV246?#3Z%(7'B\83%B9"=@C[
MBK\?MK>XOK4$75<?\JTXB]JNNL4>>OM%U=LO=C0\(HN&1Q>V#:/3K;#&7V_#
MV,OH6&5W_:FW#:,N"N(MFT!0P:6/(P[^'.-I;']?LM-C&2W+U&Z/ZDQJM\NV
MI=*.S_D,^-P\M5\PF0,J%TD1)33  I9YW[D+\]&TBZ8ZAT1YNWVCW;2GR@,'
M071'0X^1012+JLQTD 5X2KLXNOW"'#3'JO!4:>V>[:7"U?7-SLUSN!W1< B/
MX^%RI8S([8B([G+/T+YR>V[I'5?:B7@J]K0,VZKP3)3S*NK9466[U]+P2F6=
M/H]C28&T#,>V2E<W*+.C[8@^R+FQMF6TV_.B9$76VE6 EFK'5!ZM*%RM05Z"
M\5FOX^;AE"5'J^/>5[=5^0R==%4%H=MU\(<L]D8T86*[(+A(X ZE,Q$T76KJ
M]:K7*E$]K$.FIR^WM2R[$@:=ORZKH8F=QW=Y2'> C;U W[^<DM-!77T86U(]
MZJ!*!U4UT_CK0=6 AS3T3A14*2;T1]_G<8+XKZXD.W_WKMZAZD<V60Y6O6@\
MCD(BCAR\M!"U[938<*A#5%T:=-:E01_B"&CGY^Y .F*$?66QQQ.&>D(H"!)-
MQ/[/"RL3LEU;EPFIS:*NWKMVN27<>L!ZP/4^M.&@HIOR$?L>CN+99?*<;OEE
M#F52M$>, ,Z-L=UVC8ING@I71\D/'S&9=;K\<*6#O+"4$=HA'GJQV/E_Y3/Y
MVPM<)D3S=&EI(]=HNZ9.'"G+(-MH.]W:IXT4T0CW+![1E/39D(<ANJ!8]P3/
MBOP+RPU9IF%99=&FTT-/S*6>89H5=@"_A&"U4 DB<1SZNQ7":0,5Y>AR:'>;
MVC>O:1FM=E?':*=RXK08788869;1KE4K9YWKN-[2\4K!9,>^HSRWM0$]8#U@
M/>"3#'A'Q[TM'>!4;(#WLA_Y,_AGE(Z#U_\/4$L! A0#%     @ ]8-L6/@(
MZUXK#@  ;X$  !$              ( !     &-S8G(M,C R-# S,3(N:'1M
M4$L! A0#%     @ ]8-L6"4B=W&# @  B@@  !$              ( !6@X
M &-S8G(M,C R-# S,3(N>'-D4$L! A0#%     @ ]8-L6&H04YKY @  . L
M !4              ( !#!$  &-S8G(M,C R-# S,3)?9&5F+GAM;%!+ 0(4
M Q0    ( /6#;%BLBAN)JPD   I2   5              "  3@4  !C<V)R
M+3(P,C0P,S$R7VQA8BYX;6Q02P$"% ,4    " #U@VQ8Z']9'K<&  !4,0
M%0              @ $6'@  8W-B<BTR,#(T,#,Q,E]P<F4N>&UL4$L! A0#
M%     @ ]8-L6#;F]M\!)   2VP" !P              ( ! "4  &-S8G(X
M+6LQ,S$R,#(T97@Y.3%X<3,R-"YH=&U02P4&      8 !@"1 0  .TD

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>csbr-20240312_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="csbr-20240312.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
        </entity>
        <period>
            <startDate>2024-03-12</startDate>
            <endDate>2024-03-12</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-18">0000771856</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-19">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-03-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">CHAMPIONS ONCOLOGY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-11504</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">52-1401755</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">1 University Plaza, Suite 307</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Hackensack</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">07601</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">201</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">808-8400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-17">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
